Publication | Open Access

The BCR/ABL tyrosine kinase inhibitor, nilotinib, stimulates expression of IL-1β in vascular endothelium in association with downregulation of miR-3p

InflammationCytokineAngiogenesisImmunologyImmune RegulationEndothelial DysfunctionVascular BiologyMicrorna DetectionMedicineCell BiologyCell SignalingVascular Endothelium